These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17070600)

  • 1. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
    Rajagopalan G; Smart MK; Murali N; Patel R; David CS
    J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response.
    Rajagopalan G; Sen MM; Singh M; Murali NS; Nath KA; Iijima K; Kita H; Leontovich AA; Gopinathan U; Patel R; David CS
    Shock; 2006 Jun; 25(6):647-56. PubMed ID: 16721274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
    Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
    Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury.
    Krakauer T; Buckley MJ; Huzella LM; Alves DA
    Int Immunopharmacol; 2009 Sep; 9(10):1168-74. PubMed ID: 19539058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B.
    Neumann B; Engelhardt B; Wagner H; Holzmann B
    J Immunol; 1997 Feb; 158(4):1862-71. PubMed ID: 9029127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
    Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
    Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.
    Krakauer T; Buckley M
    Antimicrob Agents Chemother; 2006 Jan; 50(1):391-5. PubMed ID: 16377721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B.
    Shinbori T; Matsuki M; Suga M; Kakimoto K; Ando M
    Cell Immunol; 1996 Dec; 174(2):129-37. PubMed ID: 8954612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purpura fulminans due to Staphylococcus aureus.
    Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
    Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock.
    Rajagopalan G; Asmann YW; Lytle AK; Tilahun AY; Theuer JE; Smart MK; Patel R; David CS
    Shock; 2008 Dec; 30(6):721-8. PubMed ID: 18496243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutics targeting immune activation by staphylococcal superantigens.
    Krakauer T
    Med Sci Monit; 2005 Sep; 11(9):RA290-5. PubMed ID: 16127375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.